GlassScriptPhysician profile
Manish K Singh
NPI 1013187756
$7,147.36
in general payments reported to CMS, 2019-2025
28 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,276 · 2020: $619 · 2021: $299 · 2022: $3,166 · 2023: $1,134 · 2024: $325 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182 · Travel and Lodging: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.65 |
| Travel and Lodging | $605.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,003.53 | 2022 | |
| Medtronic, INC. | $1,290.59 | 2021-2024 | O-Arm, Prestige LP Cervical Disc System, Unid_pass |
| Abbott Laboratories | $991.65 | 2019-2025 | Proclaim, Eterna |
| Medicrea USA, Corp. | $843.74 | 2019 | |
| Camber Spine Technologies LLC | $544.58 | 2020 | |
| Si-Bone, INC. | $200.05 | 2021 | |
| Zimmer Biomet Holdings, INC. | $156.00 | 2019-2020 | |
| Medacta USA, INC. | $147.77 | 2025 | Myspine |
| Nevro Corp. | $145.02 | 2019 | |
| Providence Medical Technology, INC. | $140.21 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $115.01 | 2023 | |
| Cardiovascular Systems INC. | $111.46 | 2019 | |
| Alon Medical Technology | $69.85 | 2024 | |
| Carlsmed, INC. | $62.42 | 2022 | |
| 4web, INC. | $40.05 | 2023 | Spine Truss System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. Dba Accelus | $39.69 | 2023 | |
| Stryker Corporation | $32.85 | 2023 | |
| Kuros Biosciences USA, INC | $27.99 | 2025 | Magnetos |
| Portola Pharmaceuticals, LLC | $24.93 | 2020 | |
| Ibsa Pharma INC. | $22.66 | 2023 | Tirosint, Licart |
| Nalu Medical, INC. | $21.81 | 2024 | Nalu Neurostimulation System |
| Theragen, INC. | $19.82 | 2023 | Actastim-S |
| Radius Health, INC. | $19.69 | 2019 | |
| Medtronic USA, INC. | $18.85 | 2019 | |
| Abbvie INC. | $16.29 | 2023 | Botox |
| Virtus Pharmaceuticals LLC | $16.02 | 2023 | Levorphanol Tartrate |
| Spineology INC. | $13.04 | 2023 | Optimesh Expandable Interbody Fusion System |
| Pfizer INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.